The aim of the study is to evaluate the efficacy of the Silymarin in patient receiving antituberculosis
drugs. The study was randomized, open controlled. We chosen 90 case from
Songino-Khairkhan, Bayanzurkh, Sukhbaatar, Bayangol and Chingeltei districts which are the
highest sickness rate. We were have 3 study group which are control and cases.
Silymarin had protective effects against hepatotoxic actions of drugs used in the chemotherapy
of tuberculosis in patients.